发明名称 | Pharmaceutical compositions and method of using levodopa and carbidopa | ||
摘要 | The present invention relates to stable dosage forms and compositions of levodopa and carbidopa for the treatment of patients suffering from Parkinson's disease. The dosage forms and compositions comprise both solid and liquid formulations and result in stable pharmaceutical products. Such dosage forms and compositions comprise a metal chelator and a levodopa concentration from about 1 mg/mL to about 30 mg/mL. | ||
申请公布号 | US8815950(B2) | 申请公布日期 | 2014.08.26 |
申请号 | US200511083168 | 申请日期 | 2005.03.17 |
申请人 | Janssen Biotech, Inc. | 发明人 | Remenar Julius;Almarsson Orn;Meehan, Jr. Anthony J.;Zhang Zhong |
分类号 | A61K31/197 | 主分类号 | A61K31/197 |
代理机构 | RatnerPrestia | 代理人 | RatnerPrestia |
主权项 | 1. A pharmaceutical dosage form comprising an aqueous solution of levodopa, carbidopa, an acid, and a metal chelator, wherein the levodopa concentration is up to about 30 mg/ml, the molar ratio of levodopa to carbidopa is 3:1 to 25:1, and the solution exhibits a 7 day, 25° C. carbidopa degradation rate of less than 5%. | ||
地址 | Horsham PA US |